Ultimovacs ASA: Mandatory notification of trades by primary insider
This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act. Attachment 20240309 - Ultimovacs Notification of trade - PDMR form
Comunicato Precedente
Comunicato Successivo
This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act.
Attachment
- 20240309 - Ultimovacs Notification of trade - PDMR form
Per maggiori informazioni
Sito Web
ultimovacs.com
Ufficio Stampa
Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
;
